Health In Tech, Inc. (HIT) Revenue History
Annual and quarterly revenue from 2022 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HIT Revenue Growth
HIT Revenue Analysis (2022–2025)
As of May 8, 2026, Health In Tech, Inc. (HIT) generated trailing twelve-month (TTM) revenue of $33.3 million, reflecting explosive growth of +53.1% year-over-year. The most recent quarter (Q4 2025) recorded $7.5 million in revenue, down 11.6% sequentially.
Looking at the longer-term picture, HIT's historical revenue data shows a 3-year CAGR of +79.4%. The company achieved its highest annual revenue of $33.3 million in 2025, representing a new all-time high.
When compared to Technology sector peers including HIMS (+59.0% YoY), GDRX (-1.2% YoY), and EVLV (+40.0% YoY), HIT has underperformed the peer group in terms of revenue growth. Compare HIT vs HIMS →
HIT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HITCurrent | $33M | +53.1% | - | 4.6% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 GDRX | $797M | -1.2% | +7.7% | 13.4% | |
 EVLV | $146M | +40.0% | +98.1% | -30.7% | |
 OSCR | $11.7B | +31.9% | +81.8% | -3.4% | |
 CLVT | $2.5B | -3.3% | +14.4% | 2.9% |
HIT Historical Revenue Data (2022–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $33.3M | +71.0% | $20.9M | 62.8% | $1.5M | 4.6% |
| 2024 | $19.5M | +1.8% | $15.4M | 79.2% | $990K | 5.1% |
| 2023 | $19.2M | +231.9% | $16.8M | 88.0% | $3.4M | 17.7% |
| 2022 | $5.8M | - | $5.4M | 94.2% | $206K | 3.6% |
See HIT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HIT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HIT vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonHIT — Frequently Asked Questions
Quick answers to the most common questions about buying HIT stock.
Is HIT's revenue growth accelerating or slowing?
HIT revenue is accelerating at +53.1% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $33M. Growth momentum has increased versus prior periods.
What is HIT's long-term revenue growth rate?
Health In Tech, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +53.1% is above this long-term average.
How is HIT's revenue distributed by segment?
HIT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2025 are available for download. Segment mix reveals concentration and diversification trends.